Defibrotide

Defibrotide Dose-escalation for SOS Post-HSCT

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Defibrotide for the Treatment of Severe COVID-19

Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome

Defibrotide in Children With High Risk Kawasaki Disease

Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.

Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity

Defibrotide TMA Prophylaxis Pilot Trial

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

5-day Defibrotide Treatment for Hepatic SOS/VOD

Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide

Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study

Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation

Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients

Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver